Clayton Biotechnologies is currently working with a significant portfolio of technologies available for licensing in the biomedical domain. They have over 100 granted patents and numero them published and unpublished pending patent applications. A list of the technologies currently available for licensing can be viewed on this they site under Technologies. They are actively seeking third party arrangements to commercialize these technologies. Such arrangements may involve a license agreement with an existing biotech or pharma company. In some cases, the technology may require further evaluation and/or development by a commercial company, which can be covered by either a short-term option agreement and/or a collaborative research agreement. Also, Clayton Biotechnologies has experience working with investors and entrepreneurs, especially in situations where a technology constitutes the appropriate foundation of a start-up venture. All of the offered technologies are covered by a granted patent or patent application, and generally with international patent protection. The information listed here refers to the US patent or application in a patent family. For patents and published patent applications, the links are provided to the full texts at the USPTO they site. For unpublished patent applications, they provide a non confidential one sentence description.